EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY-NC 4.0

Correction to: One tool, multiple gains: anti-CD38 therapy in antibody-mediated rejection

Clinical Kidney Journal · 01.06.2026 · 19 (6)

DOI: 10.1093/ckj/sfag207 ↗

Kurz gefasst

Korrektur in der Zeitschrift Clinical Kidney Journal, online erschienen am 26.06.2026. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

[This corrects the article DOI: 10.1093/ckj/sfaf283.].

Zitieren

APA

(2026). Correction to: One tool, multiple gains: anti-CD38 therapy in antibody-mediated rejection. Clinical Kidney Journal, 19(6). https://doi.org/10.1093/ckj/sfag207

Vancouver

Correction to: One tool, multiple gains: anti-CD38 therapy in antibody-mediated rejection. Clinical Kidney Journal. 2026;19(6). doi:10.1093/ckj/sfag207

BibTeX
@article{euvimed2026,
  title = {Correction to: One tool, multiple gains: anti-CD38 therapy in antibody-mediated rejection},
  journal = {Clinical Kidney Journal},
  year = {2026},
  volume = {19},
  number = {6},
  doi = {10.1093/ckj/sfag207}
}
Kostenlos starten →